Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

SCIO Health Analytics Achieves Veeva CRM MyInsights Certification


WEST HARTFORD, Conn., June 19, 2018 /PRNewswire/ -- SCIO Health Analytics, a Veeva Services Partner, is pleased to announce that it is now certified on Veeva CRM MyInsights. SCIO, through its advanced predictive and prescriptive analytics capabilities and Patient Personas, can provide unique insights on patient risks and impactability, and profile the types of patients treated within a site of care.

Serving over 80 healthcare organizations including 20 provider groups and 30 health plans representing more than 90 million members, four of the top six PBMs, and clients in 30 countries for eight of the top 15 global pharmaceutical companies. SCIO's mission is to drive positive change in healthcare by delivering actionable insights to solve complicated problems simply and efficiently.

SCIO has successfully achieved Veeva's certification criteria, including completing a technical demonstration and having a number of SCIO associates pass a business-focused exam.

"SCIO provides a unique value-add to users of MyInsights," John Pagliuca, Vice President, SCIO Life Sciences said. "By combining the user's CRM and other commercial data with SCIO's predictive and prescriptive advanced analytics insights, we can provide a client's sales and commercial teams with unique insights accessible through MyInsights."

"Veeva CRM MyInsights helps customers visualize their Veeva CRM data at the point of planning and decision making to drive better field execution," Douglas Caldwell, Vice President of Customer Architecture at Veeva Systems, said.  "With CRM MyInsights, field teams are empowered with actionable insights when and where they need it, all in one place."

SCIO has developed a number of value-add offerings accessible via Veeva CRM MyInsights. SCIO has developed the Patient Persona Dashboard. This dashboard shows the spread of patients by different personas within a therapeutic area, including clinical, demographic/socio-economic and financial attributes. Heat maps show Rx utilization and Rx spend per patient across the country, down to the zip code level.

Applying its advanced analytics methodologies, SCIO has also developed the Patient Risk Detail Dashboard. The dashboard breaks down patient segment by care gaps and their prospective risk decile by comorbidities. It also provides the total patient healthcare cost and a patient count by different risk and comorbidities. Patient details such as patient ID, city, risk decile, compliance rate, and impactability score are also provided.

About SCIO Health Analytics

Based in West Hartford, Connecticut, SCIO Health Analytics is a leading health analytics solution and services company. It serves over 100 healthcare organizations representing over 130 million covered lives across the continuum including providers, health plans, PBMs, employers, health services and global life sciences companies.

SCIO provides predictive analytics and insights as a service to transform data into actionable insights, helping healthcare organizations identify opportunities and prescribe actions to drive operational performance and address the healthcare waste epidemic while improving care quality. SCIO is dedicated to helping our clients achieve optimal outcomes and decrease the total cost of care. For more information visit: www.sciohealthanalytics.com

Media Contact:

SCIO Contact:

Brandon Glenn

Michele Norton, M.S., R.N.

Amendola Communications

Senior Vice President Marketing

(216) 233-4357

(727) 815-7710

[email protected] 

[email protected]  

SOURCE SCIO Health Analytics


These press releases may also interest you

at 07:55
AMRA Medical, a health informatics and precision medicine company that is pioneering body composition research through gold-standard MRI-based analysis platforms, in collaboration with Linköping University, is pleased to announce the completion of...

at 07:55
The "mRNA-1345 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering. "mRNA-1345 Market Size, Forecast, and Emerging Insight - 2032" report provides comprehensive insights about mRNA-1345 for...

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care...

at 07:30
Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May...

at 07:30
Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto,...



News published on and distributed by: